Communiqués C-Rad AB

Actions

CRAD B

SE0002016352

Equipement et technologie médicale avancés

PEA

Marché Fermé - Nasdaq Stockholm 18:00:00 17/08/2026			Varia. 5j.	Varia. 1 janv.
36,00 ^SEK	0,00 %		-0,55 %	+12,68 %

20/07	Pareto Securities relève l'objectif de cours de C-Rad à 45 couronnes (contre 36), maintient sa recommandation à l'achat	FW
17/07	C-Rad AB (publ) publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI

Communiqués

17/07	C RAD : Interim Report Q2'26	PU
17/07	C-RAD's Interim Report Q2’26	AQ
15/05	C-RAD and SeeTreat partner to deliver personalised radiotherapy for every patient	AQ
13/05	C-RAD marks its new chapter at ESTRO 2026 with clinician-driven SGRT advances	AQ
06/05	C-RAD's Interim Report Q1’26	AQ
10/04	C-RAD publishes its annual report for 2025	AQ
12/02	C-RAD's Year-end report Q4'25	AQ
29/01	Invitation to presentation of C-RAD’s year-end report and report for the fourth quarter 2025	AQ
26/01	Tomas Blomquist appointed new CEO of C-RAD	AQ
22/10/25	C-RAD has decided to repurchase own class B shares	AQ
21/10/25	C-RAD ABs Interim Report Q3 2025	AQ
21/10/25	C-RAD advances approval of interim report for Q3 2025	AQ
21/10/25	C-RAD's CEO leaves, CFO Linda Frölén appointed acting CEO, Johan Danielsson is appointed deputy CEO	AQ
09/10/25	C Rad : Invitation to presentation of C-RAD's interim report and report for the third quarter 2025	PU
09/10/25	Invitation to presentation of C-RAD’s interim report and report for the third quarter 2025	AQ
30/09/25	C-RAD Strengthens Czech Presence with a strategically important order from Krajská Nemocnice Hospital in Liberec.	AQ
26/09/25	C-RAD showcases new developments at ASTRO 2025	AQ
28/07/25	C-RAD and iRT Systems announce partnership to advance safety in radiotherapy	AQ
18/07/25	C-RAD AB's Interim Report Q2 2025	AQ
04/07/25	C-RAD Secures 8 MSEK Service Order with Leading U.S. East Coast Healthcare Provider	AQ
30/06/25	Invitation to presentation of C-RAD’s interim report and report for the second quarter 2025	AQ
26/06/25	C-RAD Expands US Footprint with 10 MSEK Order to Equip Leading Texas Cancer Center with Surface Guided Radiation Therapy Solutions	AQ
19/06/25	C RAD : Signs Strategic Agreement with Leading Healthcare Provider in Germany's Stuttgart Region Valued at 9 MSEK	PU
19/06/25	C-RAD Signs Strategic Agreement with Leading Healthcare Provider in Germany’s Stuttgart Region Valued at 9 MSEK	AQ
04/06/25	C-RAD expands footprint in France, by joining forces with leading private healthcare provider Ramsay Santé with high-precision SGRT systems to a total value of 8.5 MSEK	AQ